You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Carbohydrate-Based Therapy of Cryptosporidiosis

    SBC: ULEX CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Cryptosporidium parvum is a significant cause of diarrheal disease of human and veterinary importance worldwide. There is currently no effective, specific therapy approved for cryptosporidiosis. The overall goal of this project is to develop safe and effective, carbohydrate-based and lectin-based therapy for this disease ...

    STTR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  2. Simulation assisted structure determination using NMR

    SBC: WXW INFO, INC.            Topic: N/A

    DESCRIPTION (provided by applicant) Development of a computational tool for high throughput protein structure determination using NMR residential dipolar coupling restraints is proposed. NMR residual dipolar couplings, which provide long-range orientation information of protein structures, are much easier to obtain experimentally than other structural information. Thi ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  3. CONTROLLED HEAT-AIDED TRANSDERMAL DRUG DELIVERY:FENTANYL

    SBC: ZARS, INC.            Topic: N/A

    DESCRIPTION (Adapted from the application): The investigators believe the fentanyl transdermal patch currently available has several limitations including the requirement of a long time to reach peak effect and that it cannot be used to treat breakthrough pain (short-lasting episodes of increased pain). ZARs' preliminary data, using its patented controlled ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  4. Modification of Intervertebral Disk Fatigue Resistance

    SBC: Ampac Biotechnology, Inc.            Topic: N/A

    DESCRIPTION (Provided by Applicant): An investigation is proposed exploring the use of biochemical reagents to improve fatigue resistance of intervertebral disc tissue. While not well quantified, the capacity of spinal tissue to withstand repetitive loading is a critically important factor in the progression of spinal osteoarthritis. Current treatments for ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  5. N/A

    SBC: ADENOSINE THERAPEUTICS, LLC            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  6. N/A

    SBC: ADENOSINE THERAPEUTICS, LLC            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  7. N/A

    SBC: ADENOSINE THERAPEUTICS, LLC            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  8. N/A

    SBC: ADENOSINE THERAPEUTICS, LLC            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  9. N/A

    SBC: Agrivax, Inc.            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  10. N/A

    SBC: Alliance Pharmaceutical Corp.            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government